Healium Medical

Company Overview

Snapshot

Founded in February 2017, Healium Medical operates with 11–50 employees. The company has raised $18.75 million across four funding rounds from three investors. In September 2022, the European Union’s EIC Fund participated in a funding round for Healium Medical.

Business overview

Healium Medical is a Health Tech & Life Sciences company focused on developing a contactless transcatheter system for the treatment of atrial fibrillation. Its core technology involves a miniature transcatheter ultrasound transducer array designed to enable circumferential pulmonary vein isolation with real-time lesion monitoring. The company's Echomplish platform provides an intuitive ablation procedure experience, featuring customized hardware and software that offers clinical insights on tissue properties and therapy progress, serving the cardiology and medical device markets globally.

Strategic signal

In September 2022, Healium Medical entered into a strategic cooperation agreement with Broncus Holding Corporation. This collaboration signals a significant step towards market expansion and validation of Healium Medical's contactless ablation technology, indicating potential for broader adoption and strategic partnerships within the medical device industry.

Company Intelligence Q&A

What is Healium Medical's primary focus?

Healium Medical focuses on the treatment of atrial fibrillation using non-contact transcatheter system technology, developing a miniature transcatheter ultrasound transducer array for contactless circumferential pulmonary vein isolation.

When was Healium Medical founded?

Healium Medical was founded in February 2017.

What is the Echomplish platform?

The Echomplish platform is Healium Medical's system designed for an intuitive ablation procedure experience, consisting of customized hardware and software that provides real-time clinical insights on tissue properties and therapy progress.

Has Healium Medical engaged in any strategic partnerships?

In September 2022, Healium Medical entered into a strategic cooperation agreement with Broncus Holding Corporation. Additionally, in June 2021, the company announced the formation of a joint venture company with Venus Medtech Inc.

Which investor participated in a funding round for Healium Medical in September 2022?

In September 2022, the European Union’s EIC Fund participated in a funding round for Healium Medical.